These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10724818)

  • 1. For severe mental illness, a higher profile and new hope.
    Brink S
    US News World Rep; 1999 Dec; 127(24):62-3. PubMed ID: 10724818
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between preventative physical health care and mental health in individuals with schizophrenia: a survey of caregivers.
    Mackell JA; Harrison DJ; McDonnell DD
    Ment Health Serv Res; 2005 Dec; 7(4):225-8. PubMed ID: 16320105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary: purchasing community perspective.
    Moore MC
    J Clin Psychiatry; 2003; 64 Suppl 17():33-4. PubMed ID: 14680426
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving mental health treatments through comparative effectiveness research.
    Wang PS; Ulbricht CM; Schoenbaum M
    Health Aff (Millwood); 2009; 28(3):783-91. PubMed ID: 19414887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left behind: the seriously mentally ill in the managed care era. Interview by Robin Dorman.
    Torrey EF; Fisher D
    Behav Healthc Tomorrow; 1998 Dec; 7(6):12-4, 31-3. PubMed ID: 10187561
    [No Abstract]   [Full Text] [Related]  

  • 7. Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications.
    Farley JF; Cline RR; Schommer JC; Hadsall RS; Nyman JA
    Clin Ther; 2008 Aug; 30(8):1524-39; discussion 1506-7. PubMed ID: 18803994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a managed behavioral health carve-out on quality of care for medicaid patients diagnosed as having schizophrenia.
    Busch AB; Frank RG; Lehman AF
    Arch Gen Psychiatry; 2004 May; 61(5):442-8. PubMed ID: 15123488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for emphasis on management over treatment of schizophrenia in clinical practice.
    Ahmed M; Osser DN; Boisvert CM; Albert LG; Aslam M
    Ann Pharmacother; 2007 Apr; 41(4):693-5. PubMed ID: 17389665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient antipsychotic treatment and inpatient costs of schizophrenia.
    Marcus SC; Olfson M
    Schizophr Bull; 2008 Jan; 34(1):173-80. PubMed ID: 17578893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
    Sankaranarayanan J; Puumala SE
    Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functionality and economic costs of outpatients with schizophrenia in Taiwan.
    Lee IH; Chen PS; Yang YK; Liao YC; Lee YD; Yeh TL; Yeh LL; Cheng SH; Chu CL
    Psychiatry Res; 2008 Apr; 158(3):306-15. PubMed ID: 18243334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
    Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
    Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in schizophrenia.
    Keks N; Mazumdar P; Shields R
    Aust Fam Physician; 2000 Feb; 29(2):129-31, 135-6. PubMed ID: 10743266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high price of schizophrenia. Georgia restricts newer anti-psychotics for Medicaid members.
    J Psychosoc Nurs Ment Health Serv; 1997 Feb; 35(2):6-7. PubMed ID: 9044174
    [No Abstract]   [Full Text] [Related]  

  • 17. [Schizophrenia].
    Finnish Psychiatrists' Association
    Duodecim; 2001; 117(24):2640-57. PubMed ID: 12183827
    [No Abstract]   [Full Text] [Related]  

  • 18. Implementation of monitoring and management guidelines for second-generation antipsychotics.
    Sernyak MJ
    J Clin Psychiatry; 2007; 68 Suppl 4():14-8. PubMed ID: 17539695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of conventional antipsychotic medications for patients with schizophrenia in a medicaid population: therapeutic and cost outcomes over 2 years.
    McCombs JS; Luo M; Johnstone BM; Shi L
    Value Health; 2000; 3(3):222-31. PubMed ID: 16464186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.